Synopsis
Synopsis
0
KDMF
0
VMF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Amdinocillin Pivoxil
2. Fl 1039
3. Fl-1039
4. Fl1039
5. Hydrochloride, Pivmecillinam
6. Mecillinam Pivaloyl Ester
7. Pivaloyl Ester, Mecillinam
8. Pivamdinocillin
9. Pivmecillinam Hydrochloride
10. Pivoxil, Amdinocillin
11. Selexid
1. Amdinocillin Pivoxil
2. 32886-97-8
3. Pivmecilinamo
4. Pivmecillinamum
5. Selexid
6. Amdinocillin Pivoxil [usan]
7. Pivmecilinamo [inn-spanish]
8. Pivmecillinamum [inn-latin]
9. Ro 10-9071
10. Amdinocillin, Pivaloyloxymethyl Ester
11. Pivmecillinam (inn)
12. Pivmecillinam [inn]
13. 1wam1oq30b
14. Amdinocillin Pivoxil (usan)
15. Ro-10-9071
16. Chebi:51210
17. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (2s-(2alpha,5alpha,6beta))-
18. Hydroxymethyl (2s,5r,6r)-6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate Pivalate (ester)
19. Coactabs
20. [(2,2-dimethylpropanoyl)oxy]methyl (2s,5r,6r)-6-[(azepan-1-ylmethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
21. [(2,2-dimethylpropanoyl)oxy]methyl 6beta-[(azepan-1-ylmethylidene)amino]-2,2-dimethylpenam-3alpha-carboxylate
22. Coactabs (tn)
23. 2,2-dimethylpropanoyloxymethyl (2s,5r,6r)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
24. Ncgc00016813-01
25. Cas-32887-03-9
26. Unii-1wam1oq30b
27. Sr-01000838842
28. Einecs 251-276-6
29. Prestwick0_001053
30. Prestwick1_001053
31. Prestwick2_001053
32. Prestwick3_001053
33. Pivmecillinam [jan]
34. Schembl33907
35. Schembl33908
36. Bspbio_001006
37. Pivmecillinam [mart.]
38. Spbio_002933
39. Pivmecillinam [who-dd]
40. Bpbio1_001108
41. Chembl1525183
42. Chembl1616433
43. Chembl1650818
44. Dtxsid7048538
45. Gtpl10922
46. Amdinocillin Pivoxil [mi]
47. Pivmecillinam, >=98% (hplc)
48. Bcp07843
49. Hy-b0810
50. Zinc4214799
51. Zinc13704173
52. Db01605
53. Ro-109071
54. Ncgc00179344-01
55. Ncgc00179344-04
56. Ncgc00179344-07
57. Ab00514713
58. D02889
59. A918810
60. Q418086
61. Sr-01000838842-2
62. Brd-k67100011-003-03-0
63. (2s,6r)-pivaloyloxymethyl 6-((e)-azepan-1-ylmethyleneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
64. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (2s-(2.alpha.,5.alpha.,6.beta.))-
| Molecular Weight | 439.6 g/mol |
|---|---|
| Molecular Formula | C21H33N3O5S |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 8 |
| Exact Mass | 439.21409234 g/mol |
| Monoisotopic Mass | 439.21409234 g/mol |
| Topological Polar Surface Area | 114 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 710 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Used to treat infections due to mecillinam-sensitive organisms such as urinary tract infections, salmonellosis and typhoid fever.
Pivmecillinam is a pivaloyloxymethyl ester of amdinocillin that is well absorbed orally, but broken down to amdinocillin in the intestinal mucosa. It is active against gram-negative organisms and used as for amdinocillin.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Anti-Infective Agents, Urinary
Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01C - Beta-lactam antibacterials, penicillins
J01CA - Penicillins with extended spectrum
J01CA08 - Pivmecillinam
Absorption
Well absorbed following oral administration.
Pivmecillinam interferes with the biosynthesis of the bacterial cell wall however its activity is slightly different from that of other penicillins and cephalosporins
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Alembic will expand their U.S. commercial portfolio with FDA-approved Pivya (pivmecillinam) for the treatment of women with uncomplicated urinary tract infections.
Lead Product(s): Pivmecillinam Hydrochloride,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Pivya
Study Phase: Approved FDFProduct Type: Antibiotic
Sponsor: Alembic Pharmaceuticals Limited
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition July 03, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Pivmecillinam Hydrochloride,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Alembic Pharmaceuticals Limited
Deal Size : Undisclosed
Deal Type : Acquisition
UTILITY Therapeutics Announces Acquisition by Alembic Pharmaceuticals Inc.
Details : Alembic will expand their U.S. commercial portfolio with FDA-approved Pivya (pivmecillinam) for the treatment of women with uncomplicated urinary tract infections.
Product Name : Pivya
Product Type : Antibiotic
Upfront Cash : Undisclosed
July 03, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Pivya (pivmecillinam) oral tablets are FDA-approved for uncomplicated UTIs in adult females caused by susceptible E. coli, Proteus mirabilis, and Staphylococcus saprophyticus.
Lead Product(s): Pivmecillinam Hydrochloride,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Pivya
Study Phase: Approved FDFProduct Type: Antibiotic
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 24, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Pivmecillinam Hydrochloride,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
FDA Approves New Treatment for Uncomplicated Urinary Tract Infections
Details : Pivya (pivmecillinam) oral tablets are FDA-approved for uncomplicated UTIs in adult females caused by susceptible E. coli, Proteus mirabilis, and Staphylococcus saprophyticus.
Product Name : Pivya
Product Type : Antibiotic
Upfront Cash : Inapplicable
April 24, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Proceeds develop and commercialize European-approved antibiotics Pivya (pivmecillinam), an oral prodrug of mecillinam, and mecillinam, an intravenous (IV) formulation for UTIs.
Lead Product(s): Pivmecillinam Hydrochloride,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Pivya
Study Phase: Approved FDFProduct Type: Antibiotic
Sponsor: AMR Action Fund
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Financing January 17, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Pivmecillinam Hydrochloride,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : AMR Action Fund
Deal Size : Undisclosed
Deal Type : Financing
Utility Therapeutics Ltd. Announces Financing Led By AMR Action Fund and FDA Acceptance
Details : Proceeds develop and commercialize European-approved antibiotics Pivya (pivmecillinam), an oral prodrug of mecillinam, and mecillinam, an intravenous (IV) formulation for UTIs.
Product Name : Pivya
Product Type : Antibiotic
Upfront Cash : Undisclosed
January 17, 2024

Details:
Pivmecillinam HCl is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Tract Infections.
Lead Product(s): Pivmecillinam Hydrochloride,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Undisclosed
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 19, 2022

Lead Product(s) : Pivmecillinam Hydrochloride,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Pivmecillinam HCl is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Tract Infections.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 19, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Pivmecillinam is an oral prodrug of mecillinam that is being developed for uncomplicated UTI (uUTI), and it has a unique mechanism of action for infections caused by Gram-negative bacteria, including extended spectrum beta-lactamases.
Lead Product(s): Pivmecillinam Hydrochloride,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Pivya
Study Phase: Phase IIProduct Type: Antibiotic
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 29, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Pivmecillinam Hydrochloride,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
UTILITY Therapeutics to Present Data at IDWeek 2021
Details : Pivmecillinam is an oral prodrug of mecillinam that is being developed for uncomplicated UTI (uUTI), and it has a unique mechanism of action for infections caused by Gram-negative bacteria, including extended spectrum beta-lactamases.
Product Name : Pivya
Product Type : Antibiotic
Upfront Cash : Inapplicable
September 29, 2021

Details:
Fosfomycin trometamol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Urinary Tract Infections.
Lead Product(s): Fosfomycin Trometamol,Nitrofurantoin,Pivmecillinam Hydrochloride
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Miscellaneous
Sponsor: Balearic Islands Health Service | Instituto de Investigación Sanitaria Aragón | Gerencia de Atención Primaria, Madrid
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 13, 2021

Lead Product(s) : Fosfomycin Trometamol,Nitrofurantoin,Pivmecillinam Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Balearic Islands Health Service | Instituto de Investigación Sanitaria Aragón | Gerencia de Atención Primaria, Madrid
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Fosfomycin trometamol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Urinary Tract Infections.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 13, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Pivmecillinam is an oral prodrug of mecillinam that is being developed for uncomplicated UTI (uUTI), and it has a unique mechanism of action for infections caused by Gram-negative bacteria, including extended-spectrum beta-lactamases.
Lead Product(s): Pivmecillinam Hydrochloride,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Pivya
Study Phase: Phase IIIProduct Type: Antibiotic
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 15, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Pivmecillinam Hydrochloride,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
UTILITY Therapeutics Preparing NDA Submission
Details : Pivmecillinam is an oral prodrug of mecillinam that is being developed for uncomplicated UTI (uUTI), and it has a unique mechanism of action for infections caused by Gram-negative bacteria, including extended-spectrum beta-lactamases.
Product Name : Pivya
Product Type : Antibiotic
Upfront Cash : Inapplicable
June 15, 2021

Details:
Ciprofloxacin is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Infections.
Lead Product(s): Ciprofloxacin,Trimethoprim,Sulfamethoxazole,Fosfomycin Trometamol,Pivmecillinam Hydrochloride,Amoxicillin Trihydrate,Clavulanate Acid
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Antibiotic
Sponsor: ZonMw
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 24, 2017

Lead Product(s) : Ciprofloxacin, Trimethoprim, Sulfamethoxazole, Fosfomycin Trometamol, Pivmecillinam Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.
Details : Ciprofloxacin is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Infections.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
July 24, 2017

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Penomax
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date : 08-08-2008
Application Number : 28104205307
Regulatory Info : Prescription
Registration Country : Denmark
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Penomax
Dosage Form : Film Coated Tablet
Dosage Strength : 400mg
Packaging :
Approval Date : 13-07-2015
Application Number : 28105503414
Regulatory Info : Prescription
Registration Country : Denmark
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Penomax
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date : 05-09-2008
Application Number : 2.01E+13
Regulatory Info : Approved
Registration Country : Sweden
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Penomax
Dosage Form : Film Coated Tablet
Dosage Strength : 400mg
Packaging :
Approval Date : 10-09-2015
Application Number : 2.01E+13
Regulatory Info : Approved
Registration Country : Sweden
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Egypt
Brand Name : Hochstitis 400
Dosage Form : Film Coated Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Egypt

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Selexide
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Selexide
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Selexide
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Not Marketed
Registration Country : Norway
Brand Name : Selexide
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Not Marketed
Registration Country : Norway

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Selexide
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Reply
13 Oct 2023
Reply
27 Feb 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
73
PharmaCompass offers a list of Pivmecillinam Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Pivmecillinam Hydrochloride manufacturer or Pivmecillinam Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pivmecillinam Hydrochloride manufacturer or Pivmecillinam Hydrochloride supplier.
A Amdinocillin Pivoxil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amdinocillin Pivoxil, including repackagers and relabelers. The FDA regulates Amdinocillin Pivoxil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amdinocillin Pivoxil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Amdinocillin Pivoxil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Amdinocillin Pivoxil supplier is an individual or a company that provides Amdinocillin Pivoxil active pharmaceutical ingredient (API) or Amdinocillin Pivoxil finished formulations upon request. The Amdinocillin Pivoxil suppliers may include Amdinocillin Pivoxil API manufacturers, exporters, distributors and traders.
click here to find a list of Amdinocillin Pivoxil suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Amdinocillin Pivoxil DMF (Drug Master File) is a document detailing the whole manufacturing process of Amdinocillin Pivoxil active pharmaceutical ingredient (API) in detail. Different forms of Amdinocillin Pivoxil DMFs exist exist since differing nations have different regulations, such as Amdinocillin Pivoxil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Amdinocillin Pivoxil DMF submitted to regulatory agencies in the US is known as a USDMF. Amdinocillin Pivoxil USDMF includes data on Amdinocillin Pivoxil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Amdinocillin Pivoxil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Amdinocillin Pivoxil suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Amdinocillin Pivoxil Drug Master File in Japan (Amdinocillin Pivoxil JDMF) empowers Amdinocillin Pivoxil API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Amdinocillin Pivoxil JDMF during the approval evaluation for pharmaceutical products. At the time of Amdinocillin Pivoxil JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Amdinocillin Pivoxil suppliers with JDMF on PharmaCompass.
A Amdinocillin Pivoxil CEP of the European Pharmacopoeia monograph is often referred to as a Amdinocillin Pivoxil Certificate of Suitability (COS). The purpose of a Amdinocillin Pivoxil CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Amdinocillin Pivoxil EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Amdinocillin Pivoxil to their clients by showing that a Amdinocillin Pivoxil CEP has been issued for it. The manufacturer submits a Amdinocillin Pivoxil CEP (COS) as part of the market authorization procedure, and it takes on the role of a Amdinocillin Pivoxil CEP holder for the record. Additionally, the data presented in the Amdinocillin Pivoxil CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Amdinocillin Pivoxil DMF.
A Amdinocillin Pivoxil CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Amdinocillin Pivoxil CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Amdinocillin Pivoxil suppliers with CEP (COS) on PharmaCompass.
A Amdinocillin Pivoxil written confirmation (Amdinocillin Pivoxil WC) is an official document issued by a regulatory agency to a Amdinocillin Pivoxil manufacturer, verifying that the manufacturing facility of a Amdinocillin Pivoxil active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Amdinocillin Pivoxil APIs or Amdinocillin Pivoxil finished pharmaceutical products to another nation, regulatory agencies frequently require a Amdinocillin Pivoxil WC (written confirmation) as part of the regulatory process.
click here to find a list of Amdinocillin Pivoxil suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Amdinocillin Pivoxil as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Amdinocillin Pivoxil API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Amdinocillin Pivoxil as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Amdinocillin Pivoxil and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Amdinocillin Pivoxil NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Amdinocillin Pivoxil suppliers with NDC on PharmaCompass.
Amdinocillin Pivoxil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amdinocillin Pivoxil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Amdinocillin Pivoxil GMP manufacturer or Amdinocillin Pivoxil GMP API supplier for your needs.
A Amdinocillin Pivoxil CoA (Certificate of Analysis) is a formal document that attests to Amdinocillin Pivoxil's compliance with Amdinocillin Pivoxil specifications and serves as a tool for batch-level quality control.
Amdinocillin Pivoxil CoA mostly includes findings from lab analyses of a specific batch. For each Amdinocillin Pivoxil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amdinocillin Pivoxil may be tested according to a variety of international standards, such as European Pharmacopoeia (Amdinocillin Pivoxil EP), Amdinocillin Pivoxil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amdinocillin Pivoxil USP).